en
Scientific article
English

Randomized non-inferiority trial to compare trimethoprim/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection

Published inThe journal of antimicrobial chemotherapy, vol. 70, no. 1, p. 264-272
Publication date2015
Abstract

The therapeutic arsenal for MRSA infections is limited. The aim of this study was to assess the non-inferiority of a combination of trimethoprim/sulfamethoxazole plus rifampicin versus linezolid alone for the treatment of MRSA infection.

Citation (ISO format)
HARBARTH, Stéphan Juergen et al. Randomized non-inferiority trial to compare trimethoprim/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection. In: The journal of antimicrobial chemotherapy, 2015, vol. 70, n° 1, p. 264–272. doi: 10.1093/jac/dku352
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0305-7453
561views
0downloads

Technical informations

Creation09/16/2014 7:55:00 AM
First validation09/16/2014 7:55:00 AM
Update time03/14/2023 10:14:10 PM
Status update03/14/2023 10:14:10 PM
Last indexation05/02/2024 3:43:17 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack